Skip to main content

Table 3 Reasons for Choosing ChEIs and Memantine

From: Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai

Reasons for choosing ChEIs Proportions of clinicians (n = 64) Reasons for choosing memantine Proportions of clinicians (n = 64)
Effectiveness 46 (71.9 %) moderate or severe AD 22 (47.8 %)
Safety 23 (35.9 %) controlling BPSD 9 (19.6 %)
Familiar with ChEIs 7 (10.9 %) poor response to ChEIs 6 (13.0 %)
Support of evidence-based research 6 (9.4 %) effectiveness 6 (13.0 %)
Convenience for patients oral taking 5 (7.8 %) fewer side-effect 3 (6.5 %)
Guidelines’ recommendation 4 (6.3 %) Patients had contraindications to ChEIs 2 (4.3 %)
The only available AD medication in the hospital 3 (4.7 %) combination use with ChEIs 1 (2.2 %)
Controlling BPSD 1 (1.6 %) support of evidence-based research 1 (2.2 %)